Skip to content

Insider · CIK 0001891841

Heidi Hunter

director

Files at STRO (SUTRO BIOPHARMA, INC.), IOBT (IO Biotech, Inc.). First filing Jun 2, 2025, latest Jun 2, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$21k bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
23Weak
IOBTbuy
IO Biotech, Inc.
$21k
15,000 shares
--

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Dec 23, 2025STRO
SUTRO BIOPHARMA, INC.
AGrant or award
Stock Option (right to buy)derivative
+1,500$0.00$01,500Dec 29, 2025
Jun 6, 2025STRO
SUTRO BIOPHARMA, INC.
AGrant or award
Stock Option (right to buy)derivative
+50,000$0.00$050,000Jun 10, 2025
Jun 5, 2025IOBT
IO Biotech, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+35,144$0.00$035,144Jun 6, 2025
May 30, 2025IOBT
IO Biotech, Inc.
POpen-market purchase
Common Stock
+15,000$1.39$21k15,000Jun 2, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Heidi Hunter: insider trades and track record | InsiderTell